tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN

Compare Urogen Pharma (URGN) vs. Competitors

Compare
650 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Urogen Pharma
$21.32
$1.02B
-6.16
98.51%
4 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.33
$880.93M
-11.06
-55.67%
4 Buy
1 Hold
0 Sell
Strong Buy
Arbutus Biopharma
$4.78
$800.07M
-18.67
23.58%
Phathom Pharmaceuticals
$14.23
$1.11B
-3.63
121.44%
6 Buy
1 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.76
$1.30B
-12.64
198.67%
9 Buy
0 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$21.47
$1.08B
-4.74
233.90%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
URGN
Urogen Pharma
21.32
10.31
93.64%
GERN
Geron
1.33
-1.56
-53.98%
ABUS
Arbutus Biopharma
4.14
0.76
22.49%
PHAT
Phathom Pharmaceuticals
13.84
7.29
111.30%
TSHA
Taysha Gene Therapies
4.48
2.98
198.67%
ZBIO
Zenas BioPharma, Inc.
21.47
14.18
194.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts